Triatomic Management’s Bruker BRKR Stock Holding History

Triatomic Management’s Portfolio BRKR Stock Details BRKR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-22,000	Closed	-$1.85M	–	41
2021 Q4	$1.85M	Buy	+22,000	New	+$1.76M	1.13%	21

Other funds holding BRKR

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

PCA

Pallas Capital Advisors Braintree, Massachusetts $3.25B AUM 40.07% 1-Year Est. Return

Triatomic Management's BRKR Position: Q1 2022 in Review

Triatomic Management sold out of Bruker (BRKR) in Q1 2022, closing a stake of 22,000 shares — an estimated $1.85M sold.

Triatomic Management first reported a position in BRKR in Q4 2021 and held it in 1 quarter. The position peaked at $1.85M in Q4 2021. 311 funds tracked by Wall St. Rank hold BRKR as of Q1 2022.

Triatomic Management reported no remaining Bruker position as of Q1 2022 after selling out during the quarter.
Triatomic Management sold 22,000 Bruker shares in Q1 2022, an estimated $1.85M.
Triatomic Management first reported a position in Bruker in Q4 2021 and held it in 1 quarter.
Triatomic Management's Bruker position peaked at $1.85M in Q4 2021.
311 funds tracked by Wall St. Rank held Bruker as of Q1 2022.

Based on Triatomic Management's 13F filing for Q1 2022, filed 12 May 2022.